Mast Cells: A New Target in the Treatment of Complex Regional Pain Syndrome?

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy

(2016) Aarat Patel et al.   Drug Design Development and Therapy

Effect of Immunomodulating Medications in Complex Regional Pain Syndrome

(2011) Maaike Dirckx et al.   CLINICAL JOURNAL OF PAIN

Mast cells and inflammation

(2010) Theoharis C. Theoharides et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Suppressing Effects of Sunitinib on Allergic Rhinitis: Previously Undefined Side Effects With Therapeutic Potential

(2010) Karel Eechoute et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Anti-inflammatory treatment of Complex Regional Pain Syndrome

(2010) Sigrid G.L. Fischer et al.   PAIN

The First Scintigraphic Detection of Tumor Necrosis Factor-Alpha in Patients with Complex Regional Pain Syndrome Type 1

(2009) Michael Bernateck et al.   ANESTHESIA AND ANALGESIA

Outcome of the Complex Regional Pain Syndrome

(2009) Marissa de Mos et al.   CLINICAL JOURNAL OF PAIN

Current Understandings on Complex Regional Pain Syndrome

(2009) Marissa de Mos et al.   Pain Practice

Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism

(2008) J. Zhou et al.   ALLERGY

Six Years Follow-up of the Levels of TNF-αand IL-6 in Patients with Complex Regional Pain Syndrome Type 1

(2008) Feikje Wesseldijk et al.   MEDIATORS OF INFLAMMATION

Tumor necrosis factor-α and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients

(2007) Feikje Wesseldijk et al.   EUROPEAN JOURNAL OF PAIN